Rossby Financial LCC Makes New $336,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Rossby Financial LCC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,026 shares of the company's stock, valued at approximately $336,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. DAVENPORT & Co LLC lifted its position in shares of HCA Healthcare by 5.8% during the first quarter. DAVENPORT & Co LLC now owns 11,985 shares of the company's stock valued at $4,141,000 after purchasing an additional 652 shares in the last quarter. Summit Trail Advisors LLC boosted its stake in shares of HCA Healthcare by 29.6% in the 1st quarter. Summit Trail Advisors LLC now owns 5,137 shares of the company's stock worth $1,775,000 after buying an additional 1,173 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of HCA Healthcare by 0.9% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 24,496 shares of the company's stock valued at $8,465,000 after acquiring an additional 229 shares during the last quarter. Mather Group LLC. boosted its position in HCA Healthcare by 19.5% in the first quarter. Mather Group LLC. now owns 1,360 shares of the company's stock worth $470,000 after purchasing an additional 222 shares during the last quarter. Finally, Alta Advisers Ltd purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at $313,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of HCA stock traded down $5.20 on Friday, reaching $372.84. The company's stock had a trading volume of 943,125 shares, compared to its average volume of 1,461,363. The company has a market capitalization of $89.69 billion, a P/E ratio of 16.58, a PEG ratio of 1.30 and a beta of 1.47. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The stock's 50 day simple moving average is $371.55 and its 200-day simple moving average is $339.10. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business earned $5.36 earnings per share. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.77%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on HCA. Wall Street Zen lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Friday, June 27th. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Royal Bank Of Canada reiterated an "outperform" rating and set a $404.00 price target (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Finally, Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Eight analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer directly owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.